Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex-Specific Differences in Primary CNS Lymphoma.
Roetzer T, Furtner J, Gesperger J, Seebrecht L, Bandke D, Brada M, Brandner-Kokalj T, Grams A, Haybaeck J, Kitzwoegerer M, Leber SL, Marhold F, Moser P, Sherif C, Trenkler J, Unterluggauer J, Weis S, Wuertz F, Hainfellner JA, Langs G, Nenning KH, Woehrer A. Roetzer T, et al. Among authors: leber sl. Cancers (Basel). 2020 Jun 16;12(6):1593. doi: 10.3390/cancers12061593. Cancers (Basel). 2020. PMID: 32560244 Free PMC article.
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J. Krassnig S, et al. Among authors: leber sl. Cancers (Basel). 2021 Mar 23;13(6):1482. doi: 10.3390/cancers13061482. Cancers (Basel). 2021. PMID: 33807050 Free PMC article.
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
Krassnig S, Leber SL, Orthmann A, Golob-Schwarzl N, Huber HJ, Wohlrab C, Skofler C, Pennauer M, Raicht A, Birkl-Toeglhofer AM, Naumann M, Mahdy-Ali K, von Campe G, Leoni M, Alcaniz J, Hoffmann J, Wälchli T, Weis S, Benesch M, Haybaeck J. Krassnig S, et al. Among authors: leber sl. J Neurooncol. 2023 Oct;165(1):91-100. doi: 10.1007/s11060-023-04451-y. Epub 2023 Oct 31. J Neurooncol. 2023. PMID: 37907716 Free PMC article.
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.
Nenning KH, Gesperger J, Furtner J, Nemc A, Roetzer-Pejrimovsky T, Choi SW, Mitter C, Leber SL, Hofmanninger J, Klughammer J, Ergüner B, Bauer M, Brada M, Chong K, Brandner-Kokalj T, Freyschlag CF, Grams A, Haybaeck J, Hoenigschnabl S, Hoffermann M, Iglseder S, Kiesel B, Kitzwoegerer M, Kleindienst W, Marhold F, Moser P, Oberndorfer S, Pinggera D, Scheichel F, Sherif C, Stockhammer G, Stultschnig M, Thomé C, Trenkler J, Urbanic-Purkart T, Weis S, Widhalm G, Wuertz F, Preusser M, Baumann B, Simonitsch-Klupp I, Nam DH, Bock C, Langs G, Woehrer A. Nenning KH, et al. Among authors: leber sl. Neurooncol Adv. 2023 Oct 18;5(1):vdad136. doi: 10.1093/noajnl/vdad136. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024240 Free PMC article.
21 results